Reddy博士的实验室 以458万英镑 收购了Haleon在美国境外的全球NRT投资组合 Dr. Reddy's Laboratories acquires Haleon's global NRT portfolio outside the US for £458M.

Reddy博士的实验室 已经以4.58亿英镑 收购了Haleon plc公司 在美国境外的 尼古丁替代疗法(NRT)品牌 Dr. Reddy's Laboratories has acquired Haleon plc's global portfolio of Nicotine Replacement Therapy (NRT) brands outside the U.S. for £458 million. 这笔交易通过其瑞士子公司进行,包括著名的品牌,如Nicotinell、Nicabate、Thive和Habitrol,涵盖30多个国家的各种NRT格式。 The deal, conducted through its Swiss subsidiary, includes prominent brands like Nicotinell, Nicabate, Thrive, and Habitrol, covering various NRT formats across over 30 countries. 这项收购旨在加强Reddy博士在消费者保健市场上的存在,特别是在场外健康产品中的存在。 This acquisition aims to enhance Dr. Reddy's presence in the consumer healthcare market, particularly in over-the-counter wellness products.